TECTONIC THERAPEUTIC, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
TECTONIC THERAPEUTIC, INC. (TECX) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$15.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-02-26
- TECTONIC THERAPEUTIC, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$15.31M.
- TECTONIC THERAPEUTIC, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$12.18M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$15.31M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$12.18M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |